Using CRISPR to Supercharge Cancer-Killing Immune CellsNews
CRISPR/Cas9 editing of T cell genomes enables better-targeted incorporation of Chimeric Antigen Receptor CD19, improving therapeutic efficacy.Read more
New Peptide Could Combat the Cause of Familial HypercholesterolemiaNews
A new peptide is being developed and tested with hopes that it will lead to better treatment options for familial hypercholesterolemia.
Phase Separation & RNA Processing as Drivers of Cancer & Neurodegenerative Disease
Feb 24 - Feb 27, 2017